Clinical research to analyze gene expression and protein expression in tape stripping samples collected from cancer patients after the initiation of chemotherapy and healthy volunteers.

JRCT ID: jRCT1030240131

Registered date:30/05/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Cancer
• Date of first enrollment: 30/05/2024
• Target sample size: 20
• Study type: Interventional
• Intervention(s): Healthy voluteers and patients treated by TS-1 are included in this study.

Outcome(s)

• Primary Outcome: Gene and protein expression analyses

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: <= 75age old
• Gender: Female

Include criteria

Cancer patients must meet 1)-4) and Healthy volunteer must be meet 1)-2) and 5).
1) Voluntary written informed consent to participation in the study.
2) Women aged 20 to 75 years at the time of informed consent.
3) Patients who started TS-1 treatment within 6 months.
4) Patients who have pigmentation at face.
5) Healthy volunteer whose age is +-10 compared to cancer patients.

Exclude criteria

<Cancer patient>
1) Patients who use moisturizer within 12 hours before sampling day.
2) Patients with skin disease wihout pigmentation at sampling area.
3) Patients with other severe diseases without cancer.
4) Patients who are strongly exposed to ultraviolet light.
5) Any conditions judged by the investigator or subinvestigator to be unsuitable for participation in the study.
<Healthy volunteer>
1) Subjects with disease such as skin disease.
2) Subjects who use medicine within 1 week before sampling day.
3) Subjects who use moisturizer within 12 hours before sampling day.
4) Subjects who are strongly exposed to ultraviolet light.
5) Any conditions judged by the investigator or subinvestigator to be unsuitable for participation in the study.

Related Information

• Primary Sponsor: Furihata Kenichi
• Source(s) of Monetary Support: Kirin Holdings